To the Editor,
We greatly appreciate the recent consensus on procalcitonin (PCT)-guided antibiotic therapy in different clinical settings published by Bartoletti et al. in the last number of this journal. PCT is the most widely actually used marker in sepsis management and a useful tool in the algorithm for antimicrobial stewardship. Monitoring PCT levels is a useful guide for the de-escalation of antibiotic therapy. Authors state that in critical care septic patients undergoing a renal replacement therapy, PCT must be used, but with caution and according with patient's clinical, radiological, biohumoral and microbiological data [1] .
Currently, extracorporeal support techniques represent a resource increasingly used in the support of critical patients hospitalized in intensive care units (ICUs).
Therefore, to improve and to deepen the generic indication contained in the document produced by the consensus, it could be useful to provide original information on the use of PCT in the specific setting of septic patient undergoing continuous renal replacement therapy (CRRT).
To assess whether PCT may be removed by CRRT, a series of 24 septic patients with acute kidney injury (AKI) undergoing continuous veno-venous hemofiltration (CVVH) were enrolled in our ICU. CVVH was performed using the Prismaflex Gambro-Hospal system (Medolla, Modena, Italy) with a polyarylethersulfone (PAES) membrane of 1.4 m 2 surface area. Serum samples were simultaneously collected from (I) peripheral blood and from multiple points of CVVH circuit, (II) prefilter site (arterial line), (III) postfilter site (venous line) and (IV) ultrafiltrate outlet line (Figure 1) . CVVH blood flow rate was 150 mL/min with an ultrafiltrate flow rate of 48.3 (±0.8) mL/min and a net ultrafiltration rate of 100 (±50) mL/h. Prefilter concentration of PCT was 14.65 (±27.4) ng/mL corresponding to a mass inlet of 1539.1 (±2885) ng, and PCT ultrafiltrate concentration was 3.13 (±6.8) ng/mL with a mean sieving coefficient (SC) of 0.15 (±0.05). Postfilter PCT concentration measured before postdilution was 17.65 (±33.89) ng/mL corresponding to a mass outlet of 994.6 (±1902.9) ng with a mean net mass transfer of 544.9 (±1024) ng. The relatively low SC and the hemoconcentration process along the filter could explain the higher PCT concentration at the level of postfilter sample site before postdilution. Considering that the amount of PCT collected in the ultrafiltrate represents only a small proportion (total mass transfer ultrafiltrate 152.7 ± 336.5), 28% of PCT mass transfer, it should be argued that PCT removal across the hemofilter is mainly due to adsorption (adsorbed mass 389.1 [±717.4]). Anyway, adsorption is often a transitory phenomenon of the first hours, that easily goes to saturation, especially with the use of small surface CRRT devices. Further studies are needed to deepen the real impact of this process. The degree of adsorption of solutes may vary with different membrane characteristics and surface (dimension of the pores and electrostatic charge). Likewise, the growing interest for new extracorporeal support with devices settled and often combined for different scopes like CRRT, CO 2 removal, extracorporeal membrane oxygenation (ECMO) or cytokines and endotoxin removal imposes particular attention to the effects on biomarkers bloodstream concentrations [2] [3] [4] [5] . Literature suggests a limited influence of convection on PCT blood concentration during extracorporeal techniques, but the role of absorption particularly in the first hours of treatment is variable depending on the characteristics of the membrane [2] . Although also in our experience diffusion and convection processes during conventional CRRT do not appear to remove a significant amount of PCT, physicians should be aware of the possible PCT limits to guide antibiotic therapy in ICU patients undergoing emerging extracorporeal techniques. Moreover, the results obtained in a specific extracorporeal support setting do not seem to be directly extensible to other different situations and therefore well-designed studies are needed to characterize the impact of adsorption and/or of newly introduced high cut-off hemofilters (HCO) on PCT serum levels.
This study meet standards of the ethical conduct of research, was approved by institutional Ethical Committee of University of Rome "Sapienza" and complied with the World Medical Association Declaration of Helsinki. 
